LAMP assays for the simple and rapid detection of clinically important urinary pathogens including the detection of resistance to 3rd generation cephalosporins.
CTX-M
Loop-mediated isothermal amplification (LAMP)
Rapid diagnosis
Resistance gene
Urinary tract infection
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
06 Oct 2021
06 Oct 2021
Historique:
received:
26
04
2021
accepted:
15
09
2021
entrez:
7
10
2021
pubmed:
8
10
2021
medline:
9
10
2021
Statut:
epublish
Résumé
Timely and accurate identification of uropathogens and determination of their antimicrobial susceptibility is paramount to the management of urinary tract infections (UTIs). The main objective of this study was to develop an assay using LAMP (Loop mediated isothermal amplification) technology for simple, rapid and sensitive detection of the most common bacteria responsible for UTIs, as well as for the detection of the most prevalent genes (encoding cefotaximases from CTX-M group 1) responsible for resistance to 3rd generation of cephalosporins. We designed primers targeting Proteus mirabilis, while those targeting Escherichia coli, Klebsiella pneumoniae and Enterococcus faecalis and the CTX-M group 1 resistance gene were benchmarked from previous studies. The amplification reaction was carried out in a warm water bath for 60 min at 63 ± 0.5 °C. The amplicons were revealed by staining with Sybr Green I. Specificity and sensitivity were determined using reference DNA extracts spiked in sterile urine samples. The analytical performance of the assays was evaluated directly on pellets of urine samples from patients suspected of UTI and compared with culture. We found a high specificity (100%) for LAMP assays targeting the selected bacteria (P. mirabilis, E. coli, K. pneumoniae, E. faecalis) and the CTX-M group 1 when using DNA extracts spiked in urine samples. The sensitivities of the assays were around 1.5 10 We showed that the LAMP assays were simple and fast. The tests showed high sensitivity and specificity using a simple procedure for DNA extraction. In addition, the assays could be performed without the need of an expensive device such as a thermal cycler. These LAMP assays could be useful as an alternative or a complementary tool to culture reducing the time to diagnosis and guiding for more effective treatment of UTIs but also as a powerful diagnostic tool in resource-limited countries where culture is not available in primary health care structures.
Sections du résumé
BACKGROUND
BACKGROUND
Timely and accurate identification of uropathogens and determination of their antimicrobial susceptibility is paramount to the management of urinary tract infections (UTIs). The main objective of this study was to develop an assay using LAMP (Loop mediated isothermal amplification) technology for simple, rapid and sensitive detection of the most common bacteria responsible for UTIs, as well as for the detection of the most prevalent genes (encoding cefotaximases from CTX-M group 1) responsible for resistance to 3rd generation of cephalosporins.
METHOD
METHODS
We designed primers targeting Proteus mirabilis, while those targeting Escherichia coli, Klebsiella pneumoniae and Enterococcus faecalis and the CTX-M group 1 resistance gene were benchmarked from previous studies. The amplification reaction was carried out in a warm water bath for 60 min at 63 ± 0.5 °C. The amplicons were revealed by staining with Sybr Green I. Specificity and sensitivity were determined using reference DNA extracts spiked in sterile urine samples. The analytical performance of the assays was evaluated directly on pellets of urine samples from patients suspected of UTI and compared with culture.
RESULTS
RESULTS
We found a high specificity (100%) for LAMP assays targeting the selected bacteria (P. mirabilis, E. coli, K. pneumoniae, E. faecalis) and the CTX-M group 1 when using DNA extracts spiked in urine samples. The sensitivities of the assays were around 1.5 10
CONCLUSION
CONCLUSIONS
We showed that the LAMP assays were simple and fast. The tests showed high sensitivity and specificity using a simple procedure for DNA extraction. In addition, the assays could be performed without the need of an expensive device such as a thermal cycler. These LAMP assays could be useful as an alternative or a complementary tool to culture reducing the time to diagnosis and guiding for more effective treatment of UTIs but also as a powerful diagnostic tool in resource-limited countries where culture is not available in primary health care structures.
Identifiants
pubmed: 34615472
doi: 10.1186/s12879-021-06720-5
pii: 10.1186/s12879-021-06720-5
pmc: PMC8495977
doi:
Substances chimiques
Cephalosporins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1037Informations de copyright
© 2021. The Author(s).
Références
Appl Biochem Biotechnol. 2011 Apr;163(7):845-50
pubmed: 20844984
Curr Opin Microbiol. 2006 Oct;9(5):466-75
pubmed: 16942899
J Parasitol Res. 2021 Jul 27;2021:6650870
pubmed: 34367688
PLoS One. 2015 Apr 08;10(4):e0122922
pubmed: 25853422
J Clin Microbiol. 2008 Aug;46(8):2800-4
pubmed: 18550738
Int J Antimicrob Agents. 2011 Aug;38(2):160-3
pubmed: 21605960
J Infect Dis. 2013 Aug 15;208(4):637-44
pubmed: 23633403
Molecules. 2015 Apr 07;20(4):6048-59
pubmed: 25853320
J Clin Microbiol. 2012 Jun;50(6):2072-4
pubmed: 22422858
Clin Infect Dis. 2004 Sep 15;39(6):873; author reply 873-4
pubmed: 15472825
PLoS Negl Trop Dis. 2015 Jul 31;9(7):e0003963
pubmed: 26230990
Int J Med Microbiol. 2013 Aug;303(6-7):305-17
pubmed: 23490927
J Virol Methods. 2007 Dec;146(1-2):317-26
pubmed: 17868915
Biotechniques. 2015 Apr 01;58(4):189-94
pubmed: 25861931
J Biochem Biophys Methods. 2007 Apr 10;70(3):499-501
pubmed: 17011631
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
PLoS One. 2018 Jul 18;13(7):e0200421
pubmed: 30021007
J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155
pubmed: 28541467
J Antimicrob Chemother. 2007 Feb;59(2):309-12
pubmed: 17138569
BMC Microbiol. 2013 Apr 17;13:85
pubmed: 23594374
J Clin Microbiol. 2016 Apr;54(4):988-93
pubmed: 26818668
Clin Chim Acta. 2018 Sep;484:171-178
pubmed: 29803898
Analyst. 2020 Jan 21;145(2):440-444
pubmed: 31793929
J Bacteriol. 2010 Sep;192(17):4413-24
pubmed: 20622068
Oral Microbiol Immunol. 2007 Apr;22(2):131-5
pubmed: 17311637
Med J Aust. 2015 Nov 2;203(9):352
pubmed: 26510798
Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):1033-1040
pubmed: 28063000
Ann Clin Microbiol Antimicrob. 2007 Mar 23;6:4
pubmed: 17378940
J Fish Dis. 2006 May;29(5):275-83
pubmed: 16677317
Diagn Microbiol Infect Dis. 2014 Jul;79(3):337-41
pubmed: 24792836
Parasitol Int. 2014 Dec;63(6):785-9
pubmed: 25086375
FEMS Immunol Med Microbiol. 2011 Jun;62(1):41-8
pubmed: 21276085
Pan Afr Med J. 2017 Mar 22;26:166
pubmed: 28674559
Postgrad Med J. 2005 Feb;81(952):83-6
pubmed: 15701738
Front Microbiol. 2015 May 22;6:519
pubmed: 26052327
Med Mal Infect. 2015 May;45(5):173-6
pubmed: 25866374
Anal Chem. 2020 Oct 6;92(19):13343-13353
pubmed: 32838514
Trop Biomed. 2016 Mar 1;33(1):135-140
pubmed: 33579150
Anal Chem. 2007 Aug 1;79(15):5608-13
pubmed: 17579496
Front Microbiol. 2017 Dec 12;8:2211
pubmed: 29312154
Front Microbiol. 2016 Jan 12;6:1548
pubmed: 26793181
Biotechniques. 2021 Jul;71(1):358-369
pubmed: 34164991
BMC Res Notes. 2014 Jul 29;7:481
pubmed: 25073620
J Clin Virol. 2013 Sep;58(1):127-31
pubmed: 23827787
J Biochem Biophys Methods. 2004 May 31;59(2):145-57
pubmed: 15163526
PLoS One. 2012;7(8):e42954
pubmed: 22900070